GlassScriptPhysician profile
Fadi Yacoub
NPI 1497216212
$2,991.56
in general payments reported to CMS, 2019-2025
17 companies · $2,060 in 2025
The $2,060 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $96.69 · 2023: $329 · 2024: $506 · 2025: $2,060.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,843 · Education: $52.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,842.87 |
| Education | $52.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $758.60 | 2024-2025 | Assure Wcd |
| Abbott Laboratories | $447.12 | 2025 | Cardiomems, Gallant |
| Alnylam Pharmaceuticals INC. | $261.37 | 2023-2025 | Amvuttra |
| Scpharmaceuticals INC. | $260.72 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $233.34 | 2025 | Camzyos |
| Boston Scientific Corporation | $162.35 | 2023-2025 | Accolade Sr, Rotapro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.60 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $155.40 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $123.56 | 2023-2025 | Verquvo |
| Biotronik INC. | $85.31 | 2023-2025 | Renamic Neo, Acticor 7 Vr-T Dx, Amvia Edge |
| Abiomed | $80.37 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $79.41 | 2025 | |
| Pfizer INC. | $52.56 | 2025 | |
| Edwards Lifesciences Corporation | $40.73 | 2025 | Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals International, Plc | $37.86 | 2024 | Arcalyst |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $29.60 | 2024 | Zio Monitor, Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $23.66 | 2023 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Yacoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.